Post navigation

EXCLUSIVE: Conservative Queensland Senator Ian Macdonald and his nephew are on a mission to tackle the stigma around hepatitis C and help improve access to life-saving treatments.

Senator Macdonald’s nephew Ian Pengelly, 44, was born with a form of haemophilia and contracted the potentially-deadly hepatitis C virus as a young teenager from the unscreened blood-clotting factor he was given as a part of his treatment during the 1980s.

This week, with the support of his uncle, Mr Pengelly is speaking publicly about his battle with the disease for the first time, and will detail his journey in a new book to be launched by Hepatitis Australia in Parliament House on Tuesday.

Around 230,000 Australians are believed to be living with chronic hepatitis C, a blood-borne virus which affects the liver and kills around 600 people each year.

Post navigation

EXCLUSIVE: Conservative Queensland
Senator Ian Macdonald and his nephew are on a mission to tackle the
stigma around hepatitis C and help improve access to life-saving
treatments.

Senator Macdonald’s nephew Ian Pengelly, 44, was born with a form
of haemophilia and contracted the potentially-deadly hepatitis C virus
as a young teenager from the unscreened blood-clotting factor he was
given as a part of his treatment during the 1980s.

This week, with
the support of his uncle, Mr Pengelly is speaking publicly about his
battle with the disease for the first time, and will detail his journey
in a new book to be launched by Hepatitis Australia in Parliament House
on Tuesday.

Around 230,000 Australians are believed to be living
with chronic hepatitis C, a blood-borne virus which affects the liver
and kills around 600 people each year.

The study is aimed at assessing the safety and immunogenicity of HCV prime-boost vaccinations ChAd3-hliNSmut and MVA-hliNSmut, administered intramuscularly in healthy volunteers and DAA treated patients. To read the entire study, click here Share This PageFollow Us … Continue reading → The post The study is aimed at assessing the safety and immunogenicity of HCV […]

The purpose of this study is to evaluate the efficacy and tolerability of DAA-based regimens in the clinical practice in HIV/HCV-coinfected patients. Hypothesis: The efficacy and tolerability of all DAA-based regimens in the clinical practice is different to what is … Continue reading → The post Real-life Security and Efficacy of DAA-based Therapy in 1,000 […]